Dr. Brenner, MD, is a psychiatrist and psychoanalyst with expertise in interventional psychiatry. He is the founder, chief executive officer, and medical director of Cambridge Biotherapies, serves as a private practice psychiatrist and psychoanalyst in Massachusetts, and is a part-time teaching associate in psychiatry at Harvard Medical School. His clinical focus includes interventional psychiatry and neuromodulation, ketamine-based treatments integrated with psychotherapy, and adult psychoanalytic care. Dr. Brenner’s research interests include psychedelic-assisted psychotherapy and psychoanalytic integration, ketamine and advanced neuromodulation approaches in psychiatry, and collaborative outpatient treatment models and psychiatric education. In addition to leading Cambridge Biotherapies, he has held Harvard Medical School faculty appointments, served as chief resident in outpatient psychiatry at Cambridge Health Alliance, and received the Mario Puzo Screenplay Award. Dr. Brenner earned his medical degree from Tufts University School of Medicine. He completed a transitional internship at Cambridge Health Alliance, followed by a psychiatry residency at Cambridge Health Alliance/Harvard Medical School. He also completed a fellowship in the Program for Psychotherapy at Cambridge Health Alliance/Harvard Medical School and post-graduate psychoanalytic training in adult psychoanalysis at the Boston Psychoanalytic Society and Institute.
Teaching Associate
Medical School
1991 – 1995
Residency
1995 – 1996
Fellowship
2000 – 2001